Radcliffe Capital Management’s Corazon Capital V838 Monoceros Corp Class A Ordinary Shares CRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-266,474
Closed -$2.69M 774
2022
Q4
$2.69M Buy
266,474
+11,083
+4% +$111K 0.09% 374
2022
Q3
$2.54M Buy
255,391
+3
+0% +$30 0.06% 534
2022
Q2
$2.5M Hold
255,388
0.06% 561
2022
Q1
$2.5M Buy
255,388
+5,388
+2% +$52.4K 0.06% 534
2021
Q4
$2.45M Hold
250,000
0.06% 477
2021
Q3
$2.43M Buy
+250,000
New +$2.43M 0.07% 415

Other funds holding CRZN

Radcliffe Capital Management's CRZN Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Corazon Capital V838 Monoceros Corp Class A Ordinary Shares (CRZN) in Q1 2023, closing a stake of 266,474 shares — an estimated $2.69M sold.

Radcliffe Capital Management first reported a position in CRZN in Q3 2021 and held it in 6 quarters. The position peaked at $2.69M in Q4 2022. 1 fund tracked by Wall St. Rank holds CRZN as of Q1 2023.

  • Radcliffe Capital Management reported no remaining Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 266,474 Corazon Capital V838 Monoceros Corp Class A Ordinary Shares shares in Q1 2023, an estimated $2.69M.
  • Radcliffe Capital Management first reported a position in Corazon Capital V838 Monoceros Corp Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
  • Radcliffe Capital Management's Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position peaked at $2.69M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Corazon Capital V838 Monoceros Corp Class A Ordinary Shares as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.